This finding is consistent with the notion that inflammation is more deleterious in HLA‐DRB1*15+ cases, and further exemplifies the contribution of genotype to immune phenotypes in MS [14, 16, 17]. Here, HLA-DRB1 is linked to myeloid sarcoma.